Testing epcoritamab plus ibrutinib for lymphoma in the brain and spinal cord
Official title: A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study is testing whether two drugs given together are safe for people with lymphoma in the central nervous system.
Read our full plain-language summary
What the trial team says
The purpose of this study is to find out whether the combination of epcoritamab and ibrutinib is a safe treatment approach that causes few or mild side effects in people with relapsed/refractory primary central nervous system lymphoma (PCNSL) or secondary central nervous system lymphoma (SCNSL).
Key facts
- Registry number
- NCT07082868
- Stage of testing
- Phase 1
- Conditions studied
- Primary Central Nervous System Lymphoma (PCNSL), Primary Central Nervous System Lymphoma, Relapsed Primary Central Nervous System Lymphoma, Refractory Primary Central Nervous System Lymphoma, Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma, Secondary Central Nervous System Lymphoma (SCNSL)
Where it is running
This trial lists 8 sites.
-
New Jersey
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) (Basking Ridge)
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) (Middletown)
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) (Montvale)
-
New York
- Memorial Sloan Kettering Commack (Limited Protocol Activities) (Commack)
- Memorial Sloan Kettering Westchester (Limited Protocol Activities) (Harrison)
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York)
- Memorial Sloan Kettering Nassau (Limited Protocol Activities) (Uniondale)
-
Utah
- University of Utah (Data Collection Only) (Salt Lake City)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.